Abtract Background/Aims: Chinese angelica polysaccharide (CAP) is the main effective ingredient of angelica sinensis and exerts anti-inflammatory and anti-apoptotic effects on many diseases. This study aimed to explore the pharmacological potential of CAP on spinal cord injury (SCI). Methods: PC12 cells were pretreated by CAP and were subjected to LPS. Transfection was performed to alter the expression of COX-1. Cell viability and apoptotic cell rate were measured by CCK-8 and flow cytometry respectively. qRT-PCR and western blot analysis were performed to assess the expression changes of pro-inflammatory cytokines, apoptosis-related factor and core kinases in PI3K/AKT pathway. Results: LPS stimulation induced significant cell damage in PC12 cells as cell viability was repressed, apoptosis was induced and the expression levels of IL-1β, IL-6, IL-8, and TNF-α were increased. CAP pretreatment protected PC12 cells against LPS-induced cell damage. Meanwhile CAP treatment reduced the expression of COX-1 even in LPS-stimulated PC12 cells. More importantly, COX-1 overexpression abolished the protective effects of CAP on LPS-injured PC12 cells. Finally, Western blot analytical results showed that CAP activated PI3K/AKT pathway also in a COX-1-dependent manner. Conclusion: CAP exerted anti-apoptotic and anti-inflammatory effects on LPS-injured PC12 cells via downregulation of COX-1.
Introduction
Spinal cord injury (SCI) is a complex and devastating condition mainly induced by combined external forces axial compression and excessive lateral bending loading [1] . SCI leads to complex cellular and molecular interactions within the central nervous system (CNS) and results in severe neurological disorders [2] . SCI has a significant impact on the health, quality of life and life expectancy of human. It also carries a heavy economic burden,
Original Paper
Accepted: 3 September, 2018
This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes as well as any distribution of modified material requires written permission.
with considerable costs associated with primary care and loss of income [3] . Despite great efforts have been paid for improving the treatment of SCI, there still remains limitations [4] [5] [6] .
The pathophysiology of SCI is characterized by an initial primary injury followed by a secondary phase of injury to the spinal cord. The secondary injury is mediated by multiple injury processes, including inflammation, free radical-induced cell death, and glutamate excitotoxicity [7] . Inflammatory response contributes a lot in the regulation of SCI pathogenesis, and seems to play a pivotal role in nerve injury and regenerative response [8] . In addition, inflammatory response may contribute to the apoptosis of neurons and oligodendrocytes as well as to the loss of neuronal function [9] . Therefore, anti-inflammation is thought to be critical for decrease of secondary degeneration and the functional deficit following SCI.
Angelica sinensis (Oliv.) Diels (family apiaceae) is a perennial umbelliferae herb that has a long history for use as a traditional Chinese medicine. It has been used for the treatment of various diseases, such as gynecological ailments, fatigue, anemia, and hypertension [10, 11] . The dried roots of angelica sinensis contain phthalides, polysaccharides, coumarin, and ferulate. Previous studies have shown that Chinese angelica polysaccharide (CAP) is the main effective ingredient of angelica sinensis and has effective functions in enhancing immunity, antivirus, anti-tumor, reducing blood glucose, antioxidant and etc [10, 12, 13] . What's more, it has been reported that CAP plays an important role in regulating inflammatory and apoptosis in SCI model [14, 15] . However, its potential on SCI and the underlying mechanism need to be further explored.
Cyclooxygenases (COXs), known as prostaglandin H synthase, are key enzyme in the conversion of arachidonic acid into prostanoids and play important roles in the accommodation of inflammation, apoptosis, blood flow, immunomodulation, mitogenesis and secondary injury [16, 17] . COX-1 is constitutively expressed in the spinal cord [18] . Besides, COX-1 has been identified to be responsible for the immediate prostanoid response to inflammatory stimuli and its expression is persistently elevated following SCI in rat model [17] . These literatures suggested that selective inhibition of COX-1 might be a promoting strategy for treating SCI.
PC12 cells, which derive from a rat pheochromocytoma and possess neuron-like characteristics, have been applied for construction of useful model system in analyzing the neurological apoptosis [19] . SCI is a severe neurological disease, and mounting researches have used PC12 cells as important adjuncts and surrogates for studies of SCI in humans [20, 21] . Therefore, in this study, we investigated the protective effects of CAP against LPS-induced injuries in PC12 cells and explored its underlying molecular mechanisms. We found that CAP attenuated LPS-induced cell injuries in PC12 cells, evidenced by the decline of apoptosis and inflammation. In addition, our results implied that CAP conferred its protective effect through inhibition of COX-1.
Materials and Methods
Cell culture and treatment PC12 cells were obtained from the American Type Culture Collection (ATCC; Rockville, MD, USA) and were used throughout the study. The cells were seeded in 75 cm 2 flask in a concentration of 1 × 10 4 cells/ml and maintained in Dulbecco's modified Eagle Medium (DMEM; Sigma-Aldrich, St. Louis, MO, USA), containing 10% fetal bovine serum (FBS; Hyclone, Logan, UT, USA), 5% horse serum (Hyclone), 100 U/ml penicillin and 100 μg/ml streptomycin (Gibco, Life Technologies, Grand Island, NY) at 37°C in an humidified atmosphere containing 5% CO 2 . Culture medium was changed every other day. Cells were treated with LPS in a series of concentration for 12 h. Prior to the treatment of LPS, the cells were incubated with different concentrations of CAP (10, 100, and 200 μg/ml) for 12 h. CAP with purity of 98% was purchased from Yongye Bio-engineering Co., Ltd. (Shanghai, China).
Transfection
The full-length COX-1 sequences were constructed into pEX plasmids (Invitrogen, CA, USA) and were referred as to pEX-COX-1. The empty plasmid was used as its negative control (pEX). Cells were transfected with the special expression vector using Lipofectamine 2000 (Invitrogen). The stably transfected cells were selected by using 0.5 mg/ml G418 (Sigma-Aldrich, St Louis, MO, USA). After approximately 4 weeks, G418-resistant cell clones were established.
Quantitative real time RT-PCR analysis
Total RNA was extracted using TRIzol reagent (Invitrogen), and was reverse transcribed into cDNA using a Reverse Transcription Kit (Takara, Dalian, China) according to the manufacturer's instructions. The expression levels of COX-1, IL-1β, IL-6, IL-8, and TNF-α were measured by qRT-PCR by using the SYBR Green Master Mix (Takara) according to manufacturer's instruction. GAPDH level was detected for use in normalization. Data were calculated using the 2 -ΔΔCt method.
CCK-8 assay
Cells were seeded in 96-well plates at a concentration of 1 × 10 4 cells/well for adherence. The cells were treated with CAP and/or LPS, and then cell viability was measured by CCK-8 Assay Kit (Dojindo, Kumamoto, Japan) according to the protocol. Briefly, treated cells were incubated with 10 μl CCK-8 solution for additional 1 h in the dark at 37°C. Optical density was measured at 450 nm wavelength using a microplate reader (Bio-Rad Laboratories, Orlando, FL, USA).
Apoptosis assay
The cell apoptosis assay was performed with an Annexin V-FITC/PI Apoptosis Detection Kit (Beyotime Biotechnology, Shanghai, China). Briefly, treated cells were collected and washed with cold PBS. Cells were resuspended in 400 µl binding buffer and subsequently incubated with a mixture of 5 µl PI and 5 µl Annexin V-FITC for 15 min at room temperature in the dark. Flow cytometry analysis was done by using a FACS can (Beckman Coulter, Fullerton, CA, USA). The data were analyzed by using FlowJo software (Tree Star Inc., Ashland, OR).
Western blot
Cell protein lysates were prepared using RIPA buffer (Beyotime Biotechnology) supplemented with protease inhibitors (Roche, Basel, Switzerland). The concentration of protein was quantified by the BCA Protein Assay Kit (Pierce, Rockford, IL, USA). 30 µg denatured protein were loaded onto sodium dodecyl sulfate-polyacrylamide gel (SDS-PAGE), electrophoresed, and then transferred to polyvinylidene fluoride (PVDF) membranes (Millipore, Bedford, MA, USA). Membranes were blocked with 5% BSA for 2 h at room temperature and then probed at 4˚C overnight with primary antibodies. The primary antibodies: anti-Bax (#5023), anti-Cleaved caspase 3 (#9662), anti-Cleaved caspase-9 (#20750), anti-Bcl-2 (#4223), anti-IL-1β (#12703), anti-IL-6 (#12153), anti-IL-8 (#8921), anti-TNF-α (#6945), anti-p-AKT (#4060), anti-AKT (#4685), anti-p-PI3K (#4228), anti-PI3K (#4249), anti-COX-1 (#2750), anti-β-actin (#4970) were all purchased from Cell Signaling Technology (Beverly, MA, USA) and were prepared in 5% BSA at a dilution of 1:1000. Then the membranes were incubated with HRP-conjugated secondary antibodies (Sigma-Aldrich) at a 1:5000 dilution for another 2 h at room temperature. ECL reagent (Beyotime Biotechnology) was used for development of signals.
Statistical analysis
All experiments were repeated three times. The results of multiple experiments are presented as the mean ± SD. Statistical analyses were performed using Graphpad 6.0 statistical software (GraphPad Software, San Diego, CA, USA). The P-values were calculated using a one-way analysis of variance (ANOVA). A P-value of <0.05 was considered to indicate a statistically significant result.
Results

LPS induced cell apoptosis and inflammation in PC12 cells
As shown in Fig. 1A , exposure of PC12 cells to 1 μg/ml LPS for 12 h did not affect cell viability. However, 5 and 10 μg/ml exposure significantly decreased cell viability by approximately 55% and 48%, respectively (both P < 0.01). As shown in Fig. 1B and 1C , 5 and 10 μg/ml LPS significantly increased apoptotic cell rate (P < 0.05 or P < 0.01), while down-regulated Bcl-2, up-regulated Bax, and cleaved caspase-3 and caspase-9. We further explored the effect of LPS on the expression of pro-inflammatory cytokines in PC12 cells. qRT-PCR (Fig. 1D ) and western blot analysis (Fig. 1E) revealed that the expression levels of IL-1β, IL-6, IL-8, and TNF-α were all remarkably increased following LPS exposure at 5
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CAP pretreatment attenuated LPS-induced cell injuries in PC12 cells
We further investigated the influence of CAP on PC12 cell injuries induced by LPS. CCK-8 assay demonstrated that pretreatment of PC12 cells with 100 and 200 μg/ml CAP significantly attenuated LPS-induced viability inhibition (both P < 0.01) (Fig. 2A) . Also, 100 and 200 μg/ml CAP significantly repressed LPS-induced apoptosis, as evidenced by the declined apoptotic cell rate (P < 0.01) (Fig. 2B) , the up-regulated Bcl-2, and the down-regulated Bax, cleaved caspase-3 and cleaved caspase-9 (Fig. 2C) . Fig. 2D showed that, the mRNA levels of IL-1β, IL-6, IL-8, and TNF-α were significantly declined with CAP pretreatment (P < 0.05, P < 0.01 or P < 0.001). Similar results were observed in protein expression levels of these proinflammatory cytokines (Fig. 2E) .
CAP suppressed COX-1 expression
COX-1 appears to play a critical in the inflammation response of SCI [17] . Thus, we explored the modulation of CAP on COX-1 expression. As shown in Fig. 3A , when treated with 100 μg/ml of CAP alone, the mRNA level of COX-1 was significantly inhibited compared with control group (P < 0.01). Meanwhile, CAP pretreatment reversed the up-regulating effect of LPS on COX-1 expression (P < 0.01) (Fig. 3A) . Similar regulation was observed in protein levels of COX-1 (Fig. 3B) .
CAP pretreatment attenuated LPS-induced cell injuries through down-regulation of COX-1
To investigate the involvement of COX-1 in CAPmediated cell apoptosis and inflammation in LPS-injured cell, COX-1 expression in PC12 cells was overexpressed by transfection with COX-1 expressing vector (pEX-COX-1). qRT-PCR and western blot analytical results indicated that, the mRNA and protein levels of COX-1 were significantly elevated after pEX-COX-1 transfection (P < 0.01) (Fig. 4A) . Fig. 4B-4F showed that, overexpression of COX-1 blocked the protective effects of CAP on LPS-injured PC12 cells, as COX-1 overexpression significantly declined cell viability (P < 0.05) (Fig. 4B) , promoted apoptotic cell rate (P < 0.05) (Fig. 4C) , up-regulated Bax, cleaved caspase-3 and cleaved caspase-9, down-regulated Bcl-2 (Fig. 4D) , and increased the expression of proinflammatory cytokines (all P < 0.01) (Fig. 4E and 4F) . The mRNA and (E) protein levels of pro-inflammatory cytokines were assessed by qRT-PCR and western blot. * P <0.05, ** P <0.01, *** P <0.001.
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Discussion
It has been reported that angelica sinensis is used in the treatment of cancers, ulcers and other diseases due to its anti-inflammatory, anti-oxidative, antiproliferative properties and immunomodulatory effect [23] [24] [25] [26] . It possess a superior clinical efficacy and fewer side effects [14] . For example, angelica sinensis polysaccharides inhibit endothelial progenitor cell senescence through the reduction of oxidative stress and activation of the AKT/hTERT pathway [27] . And it also suppresses cell growth and cell metastasis in human lung adenocarcinoma A549 cells by regulating MMPs/TIMPs and TGF-β1 [23] . Moreover, CAP protects immunological colon injury induced by TNBS and ethanol enema in rats probably due to the mechanism of anti-oxidation, anti-inflammation, immunomodulation and promotion of wound repair [28] . In agreement with previous studies showing that angelica sinensis reduces inflammatory reaction as well as apoptosis in SCI model in vivo [14, 15] , the present study demonstrated that CAP increased cell viability, and reduced apoptosis and the expression of pro-inflammatory cytokines in LPS-injured PC12 cells. Inflammation as well as apoptosis play vital roles in the secondary damage of SCI and increase the extent of pathological implications [29] . Increased production of proinflammatory cytokines, such as TNF-a, IL-1β, IL-6 and IL-8, play a pivotal role in triggering the development of SCI. Our results revealed that the expression of these core pro-inflammatory cytokines was significantly increased in PC12 cells after LPS (5 μg/ml) exposure for 12 h. However, CAP pretreatment remarked declined the expression of these cytokines, which indicated the anti-inflammatory effect of CAP.
Previous studies have shown that apoptosis, which is associated with the regulation of Bcl-2 protein family and the activation of caspases [30, 31] , is an important event in the secondary injury following SCI [32, 33] . In addition, apoptosis participates in secondary degenerative damage, and eventually results in the functional disability of the spinal cord below the injured area [34] . Our results showed that CAP could significantly reduce apoptotic cell rate and regulate apoptosis-related factors in LPS-injured PC12 cells, which indicated the anti-apoptotic effect of CAP.
Recently, it has been reported that the PI3K/AKT signaling pathway not only plays an important role in cell survival, apoptosis and protein synthesis, but also in negative regulation of LPS-induced acute inflammatory responses both in vitro and in vivo [35] . And the PI3K/AKT signaling pathway is involved in the SCI and is closely related to cell apoptosis [22] . We found that CAP reduced the expression of COX-1, which was increased by LPS treatment. COX-1 overexpression reversed the protective effects of CAP on LPSinjured PC12 cells. Additionally, we found that overexpression of COX-1 deactivated PI3K/ AKT pathway, indicating CAP activated PI3K/AKT through down-regulation of COX-1. These results suggested that CAP may attenuate LPS-induced injuries through down-regulation of COX-1 and activation of PI3K/AKT pathway in PC12 cells. And also, this study demonstrated that COX-1 expression altered the expression of p-PI3K and p-AKT, but not the total levels of PI3K and AKT. Thus we inferred that COX-1 regulated PI3K/AKT pathway might be via PTEN. Actually, a previous study has reported that COX-2, another kind of COXs with similar structure of COX-1, impacted the activation of PI3K/AKT pathway via modulation of PTEN [36] . Further investigation which focused on the regulatory relationship between COX-1 and PTEN may be helpful for the better understanding of how COX-1 regulates the PI3K/AKT pathway.
Conclusion
The present study demonstrated that CAP alleviated LPS-induced inflammation and apoptosis in PC12 cells and the mechanism may be through inhibition of COX-1 and activation of PI3K/AKT signaling pathway. These findings provided in vitro evidence that application of CAP might be an effective treatment for SCI in the future. This study might be helpful for further understanding of the pathophysiological mechanisms of SCI and developing the targeted therapies for SCI.
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